题名 | Ranibizumab 0.5 mg for Diabetic Macular Edema with Bimonthly Monitoring after a Phase of Initial Treatment: 18-Month, Multicenter, Phase IIIB RELIGHT Study. |
链接 | https://www.ncbi.nlm.nih.gov/pubmed/?term=26150052 |
https://www.ncbi.nlm.nih.gov/pubmed/?term=26150052
欢迎光临 科研速递论坛 (http://www.expaper.cn/) | Powered by Discuz! X2.5 |